Clinical Pharmacokinetics

Acknowledgement to Referees

Random-Effects Linear Modeling and Sample Size Tables for Two Special Crossover Designs of Average Bioequivalence Studies: The Four-Period, Two-Sequence, Two-Formulation and Six-Period, Three-Sequence, Three-Formulation Designs

Francisco J. Diaz, Michel J. Berg, Ron Krebill, Timothy Welty, Barry E. Gidal, Rita Alloway, Michael Privitera

Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 2: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs and Drugs Used to Treat Non-Epilepsy Disorders

Philip N. Patsalos

Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents

Sameer Doshi, Wojciech Krzyzanski, Susan Yue, Steven Elliott, Andrew Chow, Juan José Pérez-Ruixo

Differences in Cytochrome P450-Mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically Based Pharmacokinetic Modelling

Zoe E. Barter, Geoffrey T. Tucker, Karen Rowland-Yeo

Pharmacokinetics of Afatinib, a Selective Irreversible ErbB Family Blocker, in Patients with Advanced Solid Tumours

Sven Wind, Marion Schmid, Julia Erhardt, Rainer-Georg Goeldner, Peter Stopfer

Neutrophil Dynamics in Peritoneal Carcinomatosis Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Oxaliplatin

Carlos Pérez-Ruixo, Belén Valenzuela, José Esteban Peris, Pedro Bretcha-Boix, Vanesa Escudero-Ortiz, José Farré-Alegre, Juan José Pérez-Ruixo

Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates

Wei Zhao, Valérie Biran, Evelyne Jacqz-Aigrain